Publication	Data		Fish	Anatomy
Brown et al., 2021	Figure 5		pink1sh397/sh397	caudal tuberculum dopaminergic neuron th expression decreased amount, abnormal paraventricular organ dopaminergic neuron th expression decreased amount, abnormal
	Figure 6		pink1sh397/sh397	caudal tuberculum dopaminergic neuron decreased amount, abnormal caudal tuberculum neuroblast (sensu Vertebrata) decreased amount, abnormal
Hughes et al., 2020	Fig. 2.		pink1zf3398/zf3398	brain pink1 expression decreased amount, abnormal caudal tuberculum dopaminergic neuron decreased amount, abnormal
	Fig. 4.		pink1zf3398/zf3398	locomotory behavior decreased process quality, abnormal
Soman et al., 2019	Fig. 2.		pink1sh397/sh397 (AB)	calcium import into the mitochondrion decreased occurrence, abnormal
	Fig. 3.		pink1sh397/sh397 (AB)	diencephalon has fewer parts of type dopaminergic neuron, abnormal
	Fig. 4		pink1sh397/sh397 (AB)	regulation of mitochondrial membrane potential decreased process quality, abnormal
	Fig. 5.		pink1sh397/sh397 (AB) ,   pink1sh397/sh397; cms1Tg (AB)	dopaminergic neuron mitochondrion decreased area, abnormal skeletal muscle cell mitochondrion decreased volume, abnormal skeletal muscle cell mitochondrion deformed, abnormal
	Fig. 6.		pink1sh397/sh397 (AB)	diencephalon has fewer parts of type dopaminergic neuron, abnormal
Matsui et al., 2017	Fig. 4		pink1zf1035/zf1035	caudal tuberculum dopaminergic neuron decreased amount, abnormal locus coeruleus noradrenergic neuron decreased amount, abnormal
Soman et al., 2017	Fig. 2		pink1sh397/sh397	diencephalon has fewer parts of type diencephalon dopaminergic neuron, abnormal whole organism NADH dehydrogenase (ubiquinone) activity decreased occurrence, abnormal
	Fig. 3		pink1sh397/sh397	diencephalon has fewer parts of type diencephalon dopaminergic neuron, abnormal whole organism micu1 expression increased amount, abnormal
Zhang et al., 2017	Fig. 1		pink1gi2/gi2	midbrain dopaminergic neuron Ab12-th labeling decreased amount, abnormal
	Fig. 2		pink1gi2/gi2	midbrain dopaminergic neuron decreased amount, abnormal
	Fig. 4		pink1gi2/gi2	midbrain dopaminergic neuron decreased amount, abnormal
Flinn et al., 2013	Fig. 2		pink1sh397/sh397	dopaminergic neuron decreased amount, abnormal dopaminergic neuron differentiation process quality, abnormal
	Fig. 3		pink1sh397/sh397	dopaminergic neuron decreased amount, abnormal dopaminergic neuron differentiation process quality, abnormal
	Fig. 4		pink1sh397/sh397	mitochondrial electron transport, NADH to ubiquinone decreased rate, abnormal mitochondrial electron transport, ubiquinol to cytochrome c decreased rate, abnormal muscle mitochondrion decreased functionality, abnormal
	Fig. 5		pink1sh397/sh397	muscle mitochondrion increased size, abnormal
	Fig. 7		pink1sh397/sh397 ,   WT + MO7-pink1	dopaminergic neuron decreased amount, abnormal dopaminergic neuron differentiation process quality, abnormal
	Fig. 8		pink1sh397/sh397	mitochondrial electron transport, NADH to ubiquinone decreased rate, abnormal mitochondrial electron transport, ubiquinol to cytochrome c decreased rate, abnormal
	Fig. 9		pink1sh397/sh397	microglial cell activation increased process quality, abnormal
Priyadarshini et al., 2013	Fig. 1		WT + MO5-pink1	regulation of hypoxia-inducible factor-1alpha signaling pathway disrupted, abnormal regulation of superoxide dismutase activity disrupted, abnormal
	Fig. 2		WT + MO5-pink1	brain proliferative region increased size, abnormal vascular endothelial growth factor signaling pathway cellular spatiotemporal quality, abnormal
	Fig. 4		WT + MO5-pink1	catalase activity decreased process quality, abnormal heart contraction decreased process quality, abnormal regulation of reactive oxygen species metabolic process disrupted, abnormal
	Fig. 5		WT + MO5-pink1	nucleate erythrocyte increased amount, abnormal
Noble et al., 2012	Fig. 5		ot80Tg + MO4-pink1	caudal tuberculum dopaminergic neuron dead, abnormal caudal tuberculum dopaminergic neuron disheveled, abnormal
Sallinen et al., 2010	Fig. 4		WT + MO6-pink1 ,   WT + MO5-pink1	diencephalon dopaminergic neuron decreased amount, abnormal
	Fig. 5		WT + MO5-pink1	diencephalon dopaminergic neuron decreased amount, abnormal
	Fig. 6		WT + MO5-pink1	diencephalon dopaminergic neuron decreased amount, abnormal pretectum dopaminergic neuron decreased amount, abnormal
Xi et al., 2010	Fig. 2		WT + MO4-pink1 ,   WT + MO1-pink1	caudal fin shape, abnormal eye decreased size, abnormal head decreased size, abnormal pericardium edematous, abnormal
	Fig. 3		WT + MO4-pink1 ,   WT + MO1-pink1	central nervous system neuron axonogenesis disrupted, abnormal diencephalon dopaminergic neuron distributed, abnormal diencephalon dopaminergic neuron mislocalised ventrally, abnormal diencephalon dopaminergic neuron spatial pattern, abnormal dopaminergic neuron axon absent, abnormal dopaminergic neuron axon broken, abnormal dopaminergic neuron axon decreased length, abnormal
	Fig. 4		WT + MO4-pink1 ,   WT + MO1-pink1	sensory perception of touch disrupted, abnormal thigmotaxis decreased occurrence, abnormal whole organism movement behavioral quality, abnormal
	Fig. 5		WT + MO4-pink1 ,   WT + MO1-pink1	locomotion disrupted, abnormal whole organism decreased speed, abnormal
Petko et al., 2009	Fig. 5		WT + MO3-pink1	inner ear decreased size, abnormal semicircular canal development disrupted, abnormal
Anichtchik et al., 2008	Fig. 1		AB + MO1-pink1 + MO2-pink1	brain increased size, abnormal caudal fin shape, abnormal extension decreased width, abnormal eye decreased size, abnormal head decreased size, abnormal head development arrested, abnormal head low brightness, abnormal head morphology, abnormal head opaque, abnormal pericardium edematous, abnormal post-anal tail morphogenesis arrested, abnormal post-vent region curved ventral, abnormal post-vent region decreased length, abnormal sensory perception of touch arrested, abnormal somite shape, abnormal spinal cord curved ventral, abnormal
	Fig. 2		AB + MO1-pink1 + MO2-pink1	ansulate commissure aplastic, abnormal brainstem and spinal white matter disorganized, abnormal diencephalon dopaminergic neuron decreased amount, abnormal optic tectum morphology, abnormal peripheral neuron decreased amount, abnormal spinal cord primary motor neuron decreased amount, abnormal spinal cord Rohon-Beard neuron decreased amount, abnormal white matter shape, abnormal
	Fig. 3		AB + MO1-pink1 + MO2-pink1	extension decreased width, abnormal post-vent region curved ventral, abnormal post-vent region decreased length, abnormal sensory perception of touch arrested, abnormal spinal cord curved ventral, abnormal
	Fig. 5		AB + MO1-pink1 + MO2-pink1	brain apoptotic, abnormal neuron apoptotic process increased rate, abnormal spinal cord apoptotic, abnormal
	Fig. S4		AB + MO1-pink1 + MO2-pink1	diencephalon dopaminergic neuron decreased amount, abnormal